Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.41 -0.01 (-3.17%)
As of: Oct 22, 2026 · 12:09 PM EDT

Biodexa Pharmaceuticals (BDRX) Total Non-Current Liabilities (2013 - 2026)

Updated

Biodexa Pharmaceuticals (BDRX) reported Total Non-Current Liabilities of $444,096 for the quarter ended Jun 30, 2026, down 63.4% from $1.21 million a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Biodexa Pharmaceuticals posted Total Non-Current Liabilities of $850,439, down 53.3% from the prior year.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of 43.2% (years ended Dec 2020 to Dec 2025).
  • By year, Total Non-Current Liabilities came in at $1.82 million in the year ended Dec 31, 2024 (+396.1%), $366,928 in the year ended Dec 31, 2023 (-36.0%), $573,013 in the year ended Dec 31, 2022 (-32.8%) and $853,045 in the year ended Dec 31, 2021 (+503.9%).
  • The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Total Non-Current Liabilities since the quarter ended Dec 31, 2023.
  • Year over year, Total Non-Current Liabilities gained in 1 of the last four quarters, with growth averaging 59.3%.
  • The high point for year-over-year Total Non-Current Liabilities in five years was the quarter ended Dec 31, 2021 (growth of 475.4%); the low point was the quarter ended Jun 30, 2026 (a decline of 63.4%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,171.71 Bn 1,140.30 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 642.13 Bn 560.65 Bn 17.26 Bn 105.50 Bn
3 AbbVie 501.64 Bn 474.75 Bn 12.70 Bn 106.45 Bn
4 Merck 375.66 Bn 330.04 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 302.79 Bn 266.78 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn 33.91 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 193.69 Bn 167.89 Bn 6.22 Bn 35.10 Bn
9 Pfizer 172.47 Bn 119.12 Bn 10.94 Bn 97.04 Bn
10 Biodexa Pharmaceuticals 4,027.60 -23.40 Mn - 438,706.92
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 438,706.92
Dec 31, 2025 868,634.23
Jun 30, 2025 1.25 Mn
Dec 31, 2024 1.79 Mn
Jun 30, 2024 2.23 Mn
Dec 31, 2023 375,652.60
Jun 30, 2023 479,356.18
Dec 31, 2022 558,207.93
Dec 31, 2021 836,899.13
Jun 30, 2021 944,075.28
Dec 31, 2020 149,937.29
Jun 30, 2020 131,723.12
Dec 31, 2019 7.44 Mn
Jun 30, 2019 485,547.67
Dec 31, 2018 1.33 Mn
Jun 30, 2018 8.05 Mn
Dec 31, 2017 8.31 Mn
Jun 30, 2017 1.59 Mn
Dec 31, 2016 1.99 Mn
Jun 30, 2016 10.72 Mn
API Access

Biodexa Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BDRX&period=max&api_key=YOUR_API_KEY